Pennini, Meghan E.
De Marco, Anna
Pelletier, Mark
Bonnell, Jessica
Cvitkovic, Romana
Beltramello, Martina
Cameroni, Elisabetta
Bianchi, Siro
Zatta, Fabrizia
Zhao, Wei
Xiao, Xiaodong
Camara, Maria M.
DiGiandomenico, Antonio
Semenova, Elena
Lanzavecchia, Antonio
Warrener, Paul
Suzich, JoAnn
Wang, Qun
Corti, Davide http://orcid.org/0000-0002-5797-1364
Stover, C. Kendall http://orcid.org/0000-0002-7406-1696
Article History
Received: 5 May 2017
Accepted: 14 November 2017
First Online: 8 December 2017
Competing interests
: M.E.P., Q.W., M.P.,J.B, R.C, E.S, X.X, W.Z., M.M.C., A.D., P.W., J.S., C.K.S. are current or former employees of MedImmune/AstraZeneca and may own stock or stock options in the company. Patents describing the activity of the antibodies in this work have been filed by MedImmune. A.D.M., M.B, E.C., S.B, F.Z, A.L, D.C. are employees of HumAbs BioMed and may currently hold Humabs stocks or stock options. The remaining authors declare no competing financial interests.